| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.29B | 17.64B | 20.91B | 20.08B | 18.63B | 19.18B |
| Gross Profit | 5.07B | 4.74B | 5.19B | 5.24B | 5.16B | 5.60B |
| EBITDA | 2.40B | 2.67B | 2.60B | 3.11B | 3.06B | 3.41B |
| Net Income | 500.39M | 640.80M | 682.54M | 1.26B | 1.31B | 1.60B |
Balance Sheet | ||||||
| Total Assets | 51.82B | 62.55B | 50.70B | 49.11B | 41.33B | 37.89B |
| Cash, Cash Equivalents and Short-Term Investments | 4.31B | 5.13B | 5.71B | 7.13B | 4.77B | 4.64B |
| Total Debt | 33.10B | 41.72B | 31.70B | 29.04B | 25.27B | 22.13B |
| Total Liabilities | 38.61B | 48.36B | 37.05B | 37.15B | 30.45B | 29.79B |
| Stockholders Equity | 13.14B | 14.12B | 13.58B | 11.96B | 10.89B | 8.10B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -10.34B | -3.28B | 342.50M | -2.90B | 4.14B |
| Operating Cash Flow | 0.00 | -8.50B | -2.37B | 1.82B | -1.03B | 5.00B |
| Investing Cash Flow | 0.00 | -1.54B | -1.01B | -2.70B | -2.71B | -1.11B |
| Financing Cash Flow | 0.00 | 9.76B | 1.83B | 2.94B | 3.52B | -3.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥41.75B | 7.74 | ― | 6.02% | -5.07% | -26.79% | |
61 Neutral | ¥15.28B | 6.29 | ― | 2.07% | 21.00% | 70.75% | |
61 Neutral | ¥14.30B | 2.08 | ― | 0.91% | 388.20% | ― | |
59 Neutral | ¥6.18B | 12.20 | 2.90% | 4.53% | -12.48% | -34.07% | |
59 Neutral | ¥11.10B | 6.33 | ― | 2.26% | 16.09% | 31.59% | |
51 Neutral | ¥6.37B | 9.84 | ― | 4.09% | -15.64% | -7.10% |